To minimize the recurrence of a previously treated neoplasm in organ recipients, a period of 2 to 5 years without recurrence is advocated for most malignancies. However, prostate cancer is different because of its biological properties, diagnosis, and treatment.
Most prostate cancers are detected at a low stage and demonstrate slow growth after detection. Definitive treatment with radical prostatectomy affords excellent results. Renal transplant candidates with early-stage prostate cancer have a higher risk of dying on dialysis than dying from prostate cancer; therefore, renal transplant candidates with organ-confined prostate cancer should be immediately considered for transplant.
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation. 2015 Nov [Epub]
Ümit Özçelik, Hüseyin Yüce Bircan, Feza Karakayalı, Gökhan Moray, Alp Demirağ
From the Department of General Surgery, Baskent University School of Medicine, Istanbul, Turkey.